Gene-editing summit touts sickle cell success, while questions on embryo editing linger

“With so much growth in this area of therapeutic gene editing the problem of delivering therapies to patients is only going to grow," commented Professor Claire Booth (UCL GOS Institute of Child Health) on the ethical issue of ensuring therapies are fairly delivered.

Read: Science